I think we are well past 400 patients. I don't know where this assumption came from that we are only working on getting to 400 currently. We were at 200 in very early 2021. That was 5 months ago, and we've added many sites since then. Think about it.
depends on how restrictive the requirements for the trial are. Revive was set up as 'invitation only' and had to have symptom onset within 3 days - early on it was taking longer than that for the tests to come back.
If the Merck requirements are set much more loose, then they could run their numbers fairly quickly.